Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 8.74% vs -15.83% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 35.76% vs 5.20% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 28.33% vs -3.60% in Mar 2024
Compare Balance Sheet Results of Oxygenta Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
36.98
22.43
14.55
64.87%
Share Warrants & Outstandings
Total Reserve
-62.01
933.69
-995.70
-106.64%
Shareholder's Funds
-25.02
956.11
-981.13
-102.62%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
21.52
60.13
-38.61
-64.21%
Secured Loans
2.63
47.13
-44.50
-94.42%
Unsecured Loans
18.89
13.00
5.89
45.31%
Deferred Tax Assets / Liabilities
-10.80
-55.04
44.24
80.38%
Other Long Term Liabilities
0.00
0.72
-0.72
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.08
8.73
-7.65
-87.63%
Total Non-Current Liabilities
11.80
14.53
-2.73
-18.79%
Current Liabilities
Trade Payables
29.79
438.12
-408.33
-93.20%
Other Current Liabilities
15.11
58.61
-43.50
-74.22%
Short Term Borrowings
40.71
521.89
-481.18
-92.20%
Short Term Provisions
0.23
2.92
-2.69
-92.12%
Total Current Liabilities
85.85
1,021.54
-935.69
-91.60%
Total Liabilities
72.62
1,992.19
-1,919.57
-96.35%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
61.50
1,652.17
-1,590.67
-96.28%
Less: Accumulated Depreciation
21.87
1,019.06
-997.19
-97.85%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
39.63
633.11
-593.48
-93.74%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.23
56.73
-56.50
-99.59%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
0.24
-0.19
-79.17%
Long Term Loans & Advances
0.68
4.93
-4.25
-86.21%
Other Non Current Assets
1.08
59.60
-58.52
-98.19%
Total Non-Current Assets
41.68
754.61
-712.93
-94.48%
Current Assets Loans & Advances
Current Investments
0.00
0.53
-0.53
-100.00%
Inventories
20.51
690.16
-669.65
-97.03%
Sundry Debtors
5.10
345.49
-340.39
-98.52%
Cash and Bank
0.12
19.22
-19.10
-99.38%
Other Current Assets
4.58
49.97
-45.39
-90.83%
Short Term Loans and Advances
0.63
132.22
-131.59
-99.52%
Total Current Assets
30.94
1,237.58
-1,206.64
-97.50%
Net Current Assets (Including Current Investments)
-54.90
216.04
-270.94
-125.41%
Total Current Assets Excluding Current Investments
30.94
1,237.05
-1,206.11
-97.50%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
72.62
1,992.19
-1,919.57
-96.35%
Contingent Liabilities
2.91
134.46
-131.55
-97.84%
Total Debt
62.23
582.02
-519.79
-89.31%
Book Value per share (adjusted)
-6.77
42.63
-49.40
-115.88%
Annual - Borrowings
Borrowings 62.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.74% vs -15.83% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 39.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 35.76% vs 5.20% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 30.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 28.33% vs -3.60% in Mar 2024
